- Home
- VSEC vs MLTX Comparison
VSEC vs MLTX Comparison
Compare VSEC & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VSEC
- MLTX
- Stock Information
- Founded
- VSEC 1959
- MLTX 2021
- Country
- VSEC United States
- MLTX Switzerland
- Employees
- VSEC N/A
- MLTX N/A
- Industry
- VSEC Military/Government/Technical
- MLTX Biotechnology: Pharmaceutical Preparations
- Sector
- VSEC Consumer Discretionary
- MLTX Health Care
- Exchange
- VSEC Nasdaq
- MLTX Nasdaq
- Market Cap
- VSEC 3.2B
- MLTX 2.8B
- IPO Year
- VSEC N/A
- MLTX N/A
- Fundamental
- Price
- VSEC $153.50
- MLTX $52.40
- Analyst Decision
- VSEC Strong Buy
- MLTX Strong Buy
- Analyst Count
- VSEC 4
- MLTX 7
- Target Price
- VSEC $145.00
- MLTX $74.83
- AVG Volume (30 Days)
- VSEC 228.6K
- MLTX 506.4K
- Earning Date
- VSEC 07-30-2025
- MLTX 08-05-2025
- Dividend Yield
- VSEC 0.26%
- MLTX N/A
- EPS Growth
- VSEC 31.62
- MLTX N/A
- EPS
- VSEC 0.95
- MLTX N/A
- Revenue
- VSEC $1,253,105,000.00
- MLTX N/A
- Revenue This Year
- VSEC $3.23
- MLTX N/A
- Revenue Next Year
- VSEC $11.48
- MLTX N/A
- P/E Ratio
- VSEC $48.18
- MLTX N/A
- Revenue Growth
- VSEC 52.47
- MLTX N/A
- 52 Week Low
- VSEC $80.60
- MLTX $31.42
- 52 Week High
- VSEC $161.60
- MLTX $58.26
- Technical
- Relative Strength Index (RSI)
- VSEC 63.44
- MLTX 54.60
- Support Level
- VSEC $152.47
- MLTX $51.08
- Resistance Level
- VSEC $161.60
- MLTX $53.78
- Average True Range (ATR)
- VSEC 5.95
- MLTX 2.27
- MACD
- VSEC 1.73
- MLTX -0.42
- Stochastic Oscillator
- VSEC 77.70
- MLTX 55.43
About VSEC VSE Corporation
VSE Corp is a diversified aftermarket products and services company providing repair services, parts distribution, logistics, supply chain management, and consulting services for land, sea, and air transportation assets to commercial and government markets. Its operations include supply chain management solutions, parts supply and distribution, and maintenance, repair, and overhaul (MRO) services for vehicle fleet, aviation, maritime and other customers. Its reportable segments are; Aviation and Fleet. The majority of the revenue for the company is generated from the Aviation segment which is a provider of aftermarket parts distribution and MRO services for components and engine accessories supporting commercial, business, and general aviation operators.
About MLTX MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.